Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Additional Exempt Distributions

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Additional Exempt Distributions

KOO-KOO2

Sep 17, 2023 04:45PM

Re: Additional Exempt Distributions

KOO-KOO2

Oct 09, 2023 03:36PM

Re: Additional Exempt Distributions

Toinv

Oct 13, 2023 03:59PM

Re: Additional Exempt Distributions

KOO-KOO2

Oct 14, 2023 05:01AM

Toinv

Rank: President [?]

Points: 4445 [?]

Votes: 35 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Additional Exempt Distributions

in response to

Re: Additional Exempt Distributions

KOO-KOO2

posted on Oct 14, 2023 10:48AM

Thanks koo.

I'll check this out.

Cheers

Toinv

Reply New Message

Back To Forum List View

Please to post a reply